Telerehabilitation for Aphasia (TERRA) (TERRA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04682223 |
Recruitment Status :
Recruiting
First Posted : December 23, 2020
Last Update Posted : May 3, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Aphasia Stroke Stroke Rehabilitation | Behavioral: Semantically-focused therapy tasks Behavioral: Phonologically-focused therapy tasks | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | To conduct a randomized controlled phase II trial aimed at testing whether aphasia therapy delivered by a remote SLP through videoconferencing (aphasia remote therapy; ART) is non-inferior to in-clinic therapy (I-CT). |
Masking: | Single (Outcomes Assessor) |
Masking Description: | Raters will be blind to study timepoint, assignment of ART or I-CT, and treatment type (semantically- or phonologically-focused). |
Primary Purpose: | Treatment |
Official Title: | Center for the Study of Aphasia Recovery (C-STAR): Telerehabilitation for Aphasia (TERRA) |
Actual Study Start Date : | May 5, 2021 |
Estimated Primary Completion Date : | January 1, 2026 |
Estimated Study Completion Date : | March 31, 2026 |
Arm | Intervention/treatment |
---|---|
Experimental: Aphasia Remote Therapy (ART)
All participants in this group will receive 3 weeks of daily semantically-focused treatment (semantic feature analysis, semantic barrier task and verb network strengthening therapy) and 3 weeks of daily phonologically-focused treatment (phonological components analysis, phonological production task, phonological judgment task). Participants will be randomized to order of treatment. All treatment will be done remotely with a speech-language pathologist through an online platform using therapy applications. Participants will be provided with teletherapy kits (including an Internet hotspot if needed) to complete the therapy tasks. |
Behavioral: Semantically-focused therapy tasks
1) Semantic feature analysis (SFA; Boyle & Coelho, 1995; Boyle, 2004). For each pictured stimulus the participant is prompted to name the picture. Then, s/he is encouraged to produce semantically related words that represent features similar to the target word. 2) Semantic barrier task. This approach includes features of the Promoting Aphasics' Communication Effectiveness (PACE; Davis & Wilcox,1985). The goal of the task is for one participant (e.g., person with aphasia) to describe each card so that the other participant (e.g., clinician) can guess the picture on the card. 3) Verb network strengthening therapy (VNeST; Edmonds et al., 2009; 2014) targets lexical retrieval of verbs and their thematic nouns. The objective of VNeST is for the participant to generate verb-noun associates with the purpose of strengthening the connections between the verb and its thematic roles. Behavioral: Phonologically-focused therapy tasks 1) Phonological components analysis task (PCA; Leonard et al., 2008). The participant first attempts to name a given picture and then to identify the phonological features of the target words. 2) Phonological production task focuses on the identification of phonological features of targeted, imageable nouns and verbs. It requires the participant to sort picture stimuli based on the number of syllables and then to identify a hierarchy of phonological features. Once each targeted feature is identified for the pair of words, the participant is required to blend the syllables/sounds together. 3) Phonological judgment task relies on computerized presentation of verbs and nouns where participants are required to judge whether pairs of words include similar phonological features (e.g. # of syllables, initial phonemes, final phonemes, rhyming). |
Active Comparator: In-Clinic Therapy (I-CT)
All participants in this group will receive 3 weeks of daily semantically-focused treatment (semantic feature analysis, semantic barrier task and verb network strengthening therapy) and 3 weeks of daily phonologically-focused treatment (phonological components analysis, phonological production task, phonological judgment task). Participants will be randomized to order of treatment. All treatment will be done in person with a speech-language pathologist at the UofSC Aphasia Lab. |
Behavioral: Semantically-focused therapy tasks
1) Semantic feature analysis (SFA; Boyle & Coelho, 1995; Boyle, 2004). For each pictured stimulus the participant is prompted to name the picture. Then, s/he is encouraged to produce semantically related words that represent features similar to the target word. 2) Semantic barrier task. This approach includes features of the Promoting Aphasics' Communication Effectiveness (PACE; Davis & Wilcox,1985). The goal of the task is for one participant (e.g., person with aphasia) to describe each card so that the other participant (e.g., clinician) can guess the picture on the card. 3) Verb network strengthening therapy (VNeST; Edmonds et al., 2009; 2014) targets lexical retrieval of verbs and their thematic nouns. The objective of VNeST is for the participant to generate verb-noun associates with the purpose of strengthening the connections between the verb and its thematic roles. Behavioral: Phonologically-focused therapy tasks 1) Phonological components analysis task (PCA; Leonard et al., 2008). The participant first attempts to name a given picture and then to identify the phonological features of the target words. 2) Phonological production task focuses on the identification of phonological features of targeted, imageable nouns and verbs. It requires the participant to sort picture stimuli based on the number of syllables and then to identify a hierarchy of phonological features. Once each targeted feature is identified for the pair of words, the participant is required to blend the syllables/sounds together. 3) Phonological judgment task relies on computerized presentation of verbs and nouns where participants are required to judge whether pairs of words include similar phonological features (e.g. # of syllables, initial phonemes, final phonemes, rhyming). |
- Speech Production Outcome Score (SPOTS) [ Time Frame: Compare baseline score to 6 month follow-up (after treatment) score. ]A composite measure of naming (items correct on the Philadelphia Naming Test (PNT; Roach et al., 1996) and discourse words per minute (WPM)
- Improvement in overall aphasia severity [ Time Frame: Compare baseline score to 6 month follow-up (after treatment) score. ]As measured by the Western Aphasia Battery-Revised (WAB-R; Kertesz, 2007)
- Improvement in quality of life [ Time Frame: Compare baseline score to 6 month follow-up (after treatment) score. ]As measured by the Stroke Aphasia Quality of Life Scale-39 (SAQOL-39; Hilari et al., 2003)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Participants must have sustained a left hemisphere ischemic or hemorrhagic stroke at least 12 months prior to enrollment.
- Participants must primarily speak English for at least the past 20 years.
- Participants must be capable of giving informed consent or indicating another to provide informed consent.
- Participants must be between 21-80 years of age.
- Participants must be magnetic resonance imaging (MRI) compatible (e.g., no metal implants, not claustrophobic) on a 3-Tesla (3T) scanner.
Exclusion Criteria:
- Participants must not have previous neurological disease affecting the brain (e.g. history of traumatic brain injury).
- Participants must not have severely limited speech production (severe unintelligibility) and/or auditory comprehension that interferes with adequate participation in the therapy provided (i.e., WAB-R Spontaneous Speech rating scale score of 0-1 or WAB-R Comprehension score of 0-1).
- Participants must not have a history of stroke to the right hemisphere of the brain.
- Participants must not have a bilateral, cerebellar or brainstem stroke.
- Participants must not have anything that makes them be 3T MRI incompatible
- Insufficient intelligible speech to provide accurate responses with discourse/naming.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04682223
Contact: Leigh Ann Spell, Ph.D. | 803-777-2693 | SpellL@mailbox.sc.edu | |
Contact: Hanh Adkins, B.A. | 803-777-4918 | HTADKINS@mailbox.sc.edu |
United States, South Carolina | |
Medical University of South Carolina | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Contact: Leonardo Bonilha, MD, PhD 843-792-3221 bonilha@musc.edu | |
Principal Investigator: Julius Fridriksson, PhD | |
University of South Carolina | Recruiting |
Columbia, South Carolina, United States, 29208 | |
Contact: Leigh Ann Spell, PhD, CCC-SLP 803-777-2693 spelll@mailbox.sc.edu | |
Principal Investigator: Julius Fridriksson, PhD |
Principal Investigator: | Julius Fridriksson, Ph.D. | University of South Carolina |
Responsible Party: | Julius Fridriksson, Primary Investigator, University of South Carolina |
ClinicalTrials.gov Identifier: | NCT04682223 |
Other Study ID Numbers: |
Pro00105675 P50DC014664 ( U.S. NIH Grant/Contract ) |
First Posted: | December 23, 2020 Key Record Dates |
Last Update Posted: | May 3, 2022 |
Last Verified: | May 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | IPD will be shared via WebDCU™, a web based clinical trial management system developed by the Data Coordination Unit at the Medical University of South Carolina. |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Analytic Code |
Time Frame: | IPD will be shared within 1 year of completion of the study. |
Access Criteria: | IPD available upon request. |
URL: | https://dcu.musc.edu/ |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
aphasia stroke telerehabilitation speech-language therapy |
Stroke Aphasia Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases |
Cardiovascular Diseases Speech Disorders Language Disorders Communication Disorders Neurobehavioral Manifestations Neurologic Manifestations |